NASUS PHARMA LTD (NSRX) Stock Balance Sheet
NYSEARCA:NSRX • IL0012181553
Current stock price
2.75 USD
+0.05 (+1.85%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash Equivalents | 1.24M | 300.00 | 200.00 | 100.00 | |||
| Other Current Assets | 3.62M | 173.00K | 251.00K | 300.00 | |||
| Total Current Assets | 4.86M | 457.00K | 444.00K | 400.00 | |||
| Non-Current Assets | |||||||
| PPE Net | 149.00K | N/A | N/A | N/A | |||
| Other Non-Current Assets | 0.00 | 260.00K | 0.00 | 0.00 | |||
| Total Non-Current Assets | 149.00K | 260.00K | 0.00 | 0.00 | |||
| TOTAL ASSETS | 5.00M | 717.00K | 444.00K | 400.00 | |||
| LIABILITIES | |||||||
| Current Liabilities | |||||||
| Short Term Debt | 0.00 | 0.00 | 627.00K | 500.00 | |||
| Accrued Expenses | 851.00K | 987.00K | 616.00K | 400.00 | |||
| Accounts Payable | 829.00K | 651.00K | 655.00K | 800.00 | |||
| Other Current Liabilities | 483.00K | 2.29M | 2.34M | 1.60K | |||
| Total Current Liabilities | 2.16M | 3.93M | 4.24M | 3.20K | |||
| Non-Current Liabilities | |||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 73.00K | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 73.00K | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 2.24M | 3.93M | 4.24M | 3.20K | |||
| SHAREHOLDERS' EQUITY | |||||||
| Retained Earnings | -18.52M | -12.66M | -11.13M | -10.10K | |||
| Additional Paid In Capital | 21.29M | 9.43M | 7.32M | 7.30K | |||
| Common Shares | 0.00 | 20.00K | 19.00K | 0.00 | |||
| Shares Outstanding | 9.02M | 9.06M | 9.06M | 9.06M | |||
| Tangible Book Value per Share | 0.31 | -0.35 | -0.42 | -0.00 | |||
| Total Shareholders' Equity | 2.77M | -3.21M | -3.80M | -2.80K | |||
| TOTAL LIABILITIES AND EQUITY | 5.00M | 717.00K | 444.00K | 400.00 | |||
| Statistics | |||||||
| Current Ratio | 2.24 | 0.12 | 0.10 | 0.13 | |||
| Return On Assets (ROA) | -234.05% | -427.34% | -473.42% | -850.00% | |||
| Return On Equity (ROE) | -423.12% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21